Latest Breaking News On - Lauren sabella - Page 1 : vimarsana.com

MannKind (MNKD) Q4 2023 Earnings Call Transcript

MNKD earnings call for the period ending December 31, 2023.

Governor Ned Lamont to Tour MannKind June 12 as It Reaches

DANBURY, Conn., June 11, 2023 (GLOBE NEWSWIRE) MannKind Corporation (Nasdaq: MNKD) will host Connecticut Governor Ned Lamont for a tour of its.

Governor Ned Lamont to Tour MannKind June 12 as It Reaches a Manufacturing Milestone

DANBURY, Conn., June 11, 2023 MannKind Corporation will host Connecticut Governor Ned Lamont for a tour of its headquarters on Monday, June 12. The visit coincides with MannKind reaching a. | June 11, 2023

Danbury's MannnKind Corp. names new chief operating officer - Westfair Communications

MannKind Corp. (NASDAQ: MNKD), a Danbury-based company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, has named Lauren Sabella as executive vice president and chief operating officer.

Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer

Form 8-K ACORDA THERAPEUTICS INC For: Aug 16

Acorda Therapeutics Announces Resignation of Chief Operating Officer

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022. Ms. Sabella will be working in a strategic advisory role for early-stage biotechnology companies.